×

Substituted quinoxaline DNA-PK inhibitors

  • US 9,340,557 B2
  • Filed: 03/12/2014
  • Issued: 05/17/2016
  • Est. Priority Date: 03/12/2013
  • Status: Active Grant
First Claim
Patent Images

1. A compound represented by Formula (I) or a pharmaceutically acceptable salt thereof:

View all claims
  • 4 Assignments
Timeline View
Assignment View
    ×
    ×